1887

Abstract

The role of interleukin (IL)-18 in the development of the host defence system against influenza virus infection was investigated. IL-18-deficient (IL-18) C57BL/6 mice that were inoculated intranasally with the mouse-adapted strain of human influenza A/PR/8/34 (H1N1) virus showed an increased mortality with the occurrence of pathogenic changes in the lung for the first 3 days of infection, which included pronounced virus growth with massive infiltration of inflammatory cells and elevated nitric oxide production. The interferon-gamma (IFN-) level induced in the respiratory tract of IL-18 mice in the first few days after virus infection was significantly lower but, in contrast, the IL-12 level was slightly higher than the corresponding levels in wild-type C57BL/6 mice. Natural killer (NK) cell-mediated cytotoxicity in the lung of IL-18 mice was poorly activated. Local immune responses in the lung such as specific cytotoxic T lymphocyte and antibody production were induced upon influenza virus infection equally well in both strains of mice. These results indicate that IL-18 is involved in controlling influenza virus replication in the lung, especially at an early stage of infection, through activation of the innate immune mechanisms such as IFN and NK cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19596-0
2004-02-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/2/vir850423.html?itemId=/content/journal/jgv/10.1099/vir.0.19596-0&mimeType=html&fmt=ahah

References

  1. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y. M., Dietzschold B., Maeda H. 1996; Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc Natl Acad Sci U S A 93:2448–2453
    [Google Scholar]
  2. Akira S. 2000; The role of IL-18 in innate immunity. Curr Opin Immunol 12:59–63
    [Google Scholar]
  3. Bohn E., Sing A., Zumbihl R., Bielfeldt C., Okamura H., Kurimoto M., Heesemann J., Autenrieth I. B. 1998; IL-18 (IFN- γ -inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 160:299–307
    [Google Scholar]
  4. Brody J. A., Brock D. B. 1985; Epidemiologic and statistical characteristics of this United States elderly population. In Handbook of the Biology of Aging pp  3–26 Edited by Finch C. E., Schneider E. L. New York: Van Nostrand Reinhold;
    [Google Scholar]
  5. Cameron L. A., Taha R. A., Tsicopoulos A., Kurimoto M., Olivenstein R., Wallaert B., Minshall E. M., Hamid Q. A. 1999; Airway epithelium expresses interleukin-18. Eur Respir J 14:553–559
    [Google Scholar]
  6. Decker T., Lohmann-Matthes M. L. 1988; A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61–69
    [Google Scholar]
  7. Dinarello C. A. 1999; Interleukine-18. Methods 19:121–132
    [Google Scholar]
  8. Dinarello C. A. 2000; Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 11:483–486
    [Google Scholar]
  9. Dong L., Mori I., Hossain Md. J., Liu B., Kimura Y. 2003; An immunostimulatory oligonucleotide containing a cytidine–guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response. J Gen Virol 84:1623–1628
    [Google Scholar]
  10. Fujioka N., Akazawa R., Ohashi K., Fujii M., Ikeda M., Kurimoto M. 1999; Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73:2401–2409
    [Google Scholar]
  11. Glezen W. P., Paredes A., Tader L. H. 1980; Influenza in children. Relationship to other respiratory agents. JAMA 243:1345–1349
    [Google Scholar]
  12. Greenberger M. J., Strieter R. M., Kunkel S. L., Danforth J. M., Laichalk L. L., McGillicuddy D. C., Standiford T. J. 1996; Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumoniae . J Infect Dis 173:159–165
    [Google Scholar]
  13. Hennet T., Ziltener H. J., Frei K., Peterhans E. 1992; A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149:932–939
    [Google Scholar]
  14. Hunter C. A., Timans J., Pisacane P. 7 other authors 1997; Comparison of the effects of interleukin-1alpha, interleukin-1beta and interleukin-gamma-inducing factor on the production of interferon-gamma by natural killer. Eur J Immunol 27:2787–2792
    [Google Scholar]
  15. Kawakami K., Qureshi M. H., Zhang T., Okamura H., Kurimoto M., Saito A. 1997; IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN- γ production. J Immunol 159:5528–5534
    [Google Scholar]
  16. Kohno K., Kataoka J., Ohtsuki T., Suemoto Y., Okamoto I., Usui M., Ikeda M., Kurimoto M. 1997; IFN- γ -inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158:1541–1550
    [Google Scholar]
  17. Lauw F. N., Simpson A. J., Prins J. M. 7 other authors 1999; Elevated plasma concentrations of interferon (IFN)- γ and the IFN- γ -inducing cytokines interleukin (IL)-18, IL-12 and IL-15 in severe melioidosis. J Infect Dis 180:1878–1885
    [Google Scholar]
  18. Lauw F. N., Branger J., Florquin S., Speelman P., van Deventer S. J., Akira S., van der Poll T. 2002; IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol 168:372–378
    [Google Scholar]
  19. Liu B., Mori I., Hossain Md. J., Dong L., Kimura Y. 2001; Peroral vaccination with a temperature-sensitive mutant of parainfluenza virus type 1 protects mice against respiratory challenge infection. J Gen Virol 82:2889–2894
    [Google Scholar]
  20. Liu B., Mori I., Hossain Md. J., Dong L., Chen Z., Kimura Y. 2003; Local immune responses to influenza virus infection in mice with a targeted disruption of perforin gene. Microb Pathog 34:161–167
    [Google Scholar]
  21. Mori I., Komatsu T., Takeuchi K., Nakakuki K., Sudo M., Kimura Y. 1995; Viremia induced by influenza virus. Microb Pathog 19:237–244
    [Google Scholar]
  22. Mori I., Hossain Md. J., Takeda K., Okamura H., Imai Y., Kohsaka S., Kimura Y. 2001; Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 287:163–170
    [Google Scholar]
  23. Netea M. G., Fantuzzi G., Kullberg B. J., Stuyt R. L., Pulido E. J., McIntyre R. C. Jr, Joosten L. A., van der Meer J. W., Dinarello C. A. 2000; Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol 164:2644–2649
    [Google Scholar]
  24. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., Nakanishi K. 1998; Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70:281–312
    [Google Scholar]
  25. Pien G. C., Satoskar A. R., Takeda K., Akira S., Biron C. A. 2000; Cutting edge: selective IL-18 requirements for induction of compartmental IFN- γ responses during viral infection. J Immunol 165:4787–4791
    [Google Scholar]
  26. Ryan L. K., Copeland L. R., Daniels M. J., Costa E. R., Selgrade M. J. 2002; Proinflammatory and Th1 cytokine alterations following ultraviolet radiation enhancement of disease due to influenza infection in mice. Toxicol Sci 67:88–97
    [Google Scholar]
  27. Skerrett S. J. 1994; Host defenses against respiratory infection. Med Clin N Am 78:941–966
    [Google Scholar]
  28. Sugawara I., Yamada H., Kaneko H., Mizuno S., Takeda K., Akira S. 1999; Role of interleukine-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 67:2585–2589
    [Google Scholar]
  29. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., Akira S. 1998; Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383–390
    [Google Scholar]
  30. Takizawa T., Matsukawa S., Higuchi Y., Nakamura S., Nakanishi Y., Fukuda R. 1993; Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74:2347–2355
    [Google Scholar]
  31. Tanaka-Kataoka M., Kunikata T., Takayama S., Iwaki K., Ohashi K., Ikeda M., Kurimoto M. 1999; In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 11:593–599
    [Google Scholar]
  32. Tsai W. C., Strieter R. M., Wilkowski J. M., Bucknell K. A., Burdick M. D., Lira S. A., Standiford T. J. 1998; Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J Immunol 161:2435–2440
    [Google Scholar]
  33. Tsutsui H., Nakanishi K., Matsui K., Higashino K., Okamura H., Miyazawa Y., Kaneda K. 1996; IFN- γ -inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 157:3967–3973
    [Google Scholar]
  34. Van Reeth K., Van Gucht S., Pensaert M. 2002; Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol 15:583–594
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19596-0
Loading
/content/journal/jgv/10.1099/vir.0.19596-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error